Free Trial

Goldman Sachs Group Inc. Sells 171,398 Shares of Trupanion, Inc. $TRUP

Trupanion logo with Finance background

Key Points

  • Goldman Sachs Group Inc. reduced its stake in Trupanion, Inc. by 49.1%, owning approximately $6.62 million worth of the company's shares after selling 171,398 shares during the 1st quarter.
  • Analyst upgrades for Trupanion include a price target increase from $62.00 to $67.00 by Piper Sandler, with a consensus rating of “Moderate Buy” and a target price of $54.17.
  • Trupanion's quarterly earnings beat estimates, reporting $0.22 earnings per share and revenue of $353.56 million, reflecting a 12.3% year-over-year increase.
  • Five stocks to consider instead of Trupanion.

Goldman Sachs Group Inc. lessened its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 49.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 177,653 shares of the financial services provider's stock after selling 171,398 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.42% of Trupanion worth $6,621,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Jump Financial LLC grew its stake in shares of Trupanion by 27.5% in the first quarter. Jump Financial LLC now owns 87,673 shares of the financial services provider's stock worth $3,268,000 after purchasing an additional 18,919 shares during the last quarter. Palisade Capital Management LP grew its stake in shares of Trupanion by 36.7% in the first quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock worth $9,107,000 after purchasing an additional 65,653 shares during the last quarter. Russell Investments Group Ltd. grew its stake in shares of Trupanion by 277.7% in the first quarter. Russell Investments Group Ltd. now owns 34,643 shares of the financial services provider's stock worth $1,291,000 after purchasing an additional 25,471 shares during the last quarter. Banque Pictet & Cie SA bought a new stake in shares of Trupanion in the first quarter worth $439,000. Finally, GAMMA Investing LLC grew its stake in shares of Trupanion by 3,474.4% in the first quarter. GAMMA Investing LLC now owns 61,086 shares of the financial services provider's stock worth $2,277,000 after purchasing an additional 59,377 shares during the last quarter.

Analyst Ratings Changes

Several analysts recently weighed in on TRUP shares. Stifel Nicolaus boosted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Finally, Piper Sandler upped their price target on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $54.17.

View Our Latest Report on TRUP

Insider Buying and Selling

In related news, CFO Fawwad Qureshi sold 2,800 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total value of $127,568.00. Following the completion of the transaction, the chief financial officer directly owned 6,451 shares of the company's stock, valued at approximately $293,907.56. This trade represents a 30.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Darryl Rawlings sold 30,369 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $44.70, for a total transaction of $1,357,494.30. Following the completion of the transaction, the director directly owned 1,413,281 shares of the company's stock, valued at approximately $63,173,660.70. This trade represents a 2.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 52,800 shares of company stock valued at $2,364,335 over the last three months. Insiders own 5.42% of the company's stock.

Trupanion Stock Down 1.0%

Shares of TRUP traded down $0.46 on Friday, reaching $44.35. The company's stock had a trading volume of 112,493 shares, compared to its average volume of 583,758. Trupanion, Inc. has a twelve month low of $31.00 and a twelve month high of $57.90. The firm has a fifty day moving average of $47.41 and a 200-day moving average of $44.48. The stock has a market capitalization of $1.91 billion, a PE ratio of 170.21 and a beta of 1.72. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The firm had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same period in the prior year, the firm earned ($0.14) EPS. The company's revenue was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

About Trupanion

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.